Personalis to Announce Third Quarter 2022 Financial Results
October 19 2022 - 4:01PM
Business Wire
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics
for precision oncology, announced today that it will release its
third quarter 2022 financial results on Wednesday, November 2,
2022. In conjunction with the release, Personalis will host a
conference call and webcast that day at 2:00 p.m. Pacific Time /
5:00 p.m. Eastern Time to discuss its financial results and recent
highlights.
To access the live call via telephone, please register in
advance using the link here. Upon registering, each participant
will receive an email confirmation with dial-in numbers and a
unique personal PIN that can be used to join the call.
The live webinar of the call may be accessed by visiting the
Events section of the company's website at
investors.personalis.com. A replay of the webinar will be available
shortly after the conclusion of the call and will be archived on
the company's website.
About Personalis
Personalis, Inc. is a leader in advanced cancer genomics,
enabling the next generation of precision cancer therapies and
diagnostics. The Personalis NeXT Platform® is designed to adapt to
the complex and evolving understanding of cancer, providing its
biopharmaceutical customers and clinicians with information on all
of the approximately 20,000 human genes, together with the immune
system, from a single sample. To enable cancer sequencing,
Personalis' Clinical Laboratory was built with a focus on clinical
accuracy, quality, big data, scale, and efficiency. The laboratory
is GxP-aligned as well as Clinical Laboratory Improvement
Amendments of 1988-certified and College of American
Pathologists-accredited. For more information, visit the Personalis
website and follow Personalis on LinkedIn and Twitter.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20221019005051/en/
Investor Relations Contact for Personalis: Caroline Corner
investors@personalis.com www.westwicke.com 415-202-5678
Media Contact for Personalis: Jennifer Temple pr@personalis.com
www.personalis.com 650-752-1300
Personalis (NASDAQ:PSNL)
Historical Stock Chart
From Apr 2024 to May 2024
Personalis (NASDAQ:PSNL)
Historical Stock Chart
From May 2023 to May 2024